Flamigel RT
Share
Flamigel® RT is a hydro-active colloid gel designed to protect and care for the skin during radiotherapy.
Flamigel® RT is a hydro-active collid gel, which, when applied to the skin, builds a barrier that protects the skin against radiotherapy induced skin reactions. Starting from day one, it reduce the incidence of skin reactions, providing comfort and enabling uninterrupted treatment. Its advanced formulation supports skin integrity and promotes healing, leading to significantly improved patient outc
15/06/2026
Ease your patients' discomfort with Flamigel® RT. Clinically proven to alleviate radiotherapy-induced skin reactions, it offers reliable relief. Recommend Flamigel® RT to empower your patients in managing their pain during treatment.
1.Johnson K, Fenton G, and White RJ. (2021) Radiation dermatitis: the evaluation of a new topical therapy for the treatment and prevention of radiation-induced skin damage and moist desquamation: a multicentre UK case cohort study. Journal of Radiotherapy in Practice page 1 of 5. doi: 10.1017/S1460396920001077.
Guide your patients in skincare protection during radiotherapy. Share precautionary tips to reduce the risk of skin damage during their treatment. Introduce your patients to the benefits of Flamigel® RT from day one, which can form a protective barrier and effectively safeguard their skin from further damage.
Recommend Flamigel® RT to your patients undergoing radiotherapy to reduce the incidence of radiotherapy-induced moist desquamation (RIMD), soothe exposed skin areas, and accelerate cell renewal. With your expert "companion", radiotherapy-induced skin reactions (RISR) no longer compromise your patients' treatment.
22/04/2026
According to an independent study*, radiodermatitis affects 94% of breast cancer patients during radiotherapy. Make a difference by recommending Flamigel® RT from day 1 of treatment and help reduce the incidence of skin reactions, ensuring better care for your patients.
*Censabella S et al., Efficacy of a hydroactive colloid gel versus historical controls for the prevention of radiotherapy induced moist desquamation in breast cancer patients. Eur J Oncol Nurs. 2017;29:1-7.
Flamigel® RT: reduce radiodermatitis risk Flamigel® RT is a hydro-active colloid gel for the symptomatic treatment of low grade radiotherapy-induced skin reactions.
06/04/2026
Clinical evidence* showed that Flamigel® RT reduced the incidence of moist desquamation by 80% versus standard care in radiotherapy patients.
A clear difference that highlights the value of recommending Flamigel® RT from day one, to help protect skin throughout treatment.
*Censabella S et al., Efficacy of a hydroactive colloid gel versus historical controls for the prevention of radiotherapy induced moist desquamation in breast cancer patients. Eur J Oncol Nurs. 2017;29:1-7.
Flamigel® RT. 80% less moist desquamation Flamigel® RT is a hydro-active colloid gel for the symptomatic treatment of low grade radiotherapy-induced skin reactions.
Click here to claim your Sponsored Listing.
Telephone
Address
1 Northumberland Avenue London
London
WC2N5BW
